FOXO TECHNOLOGIES INC. Accrued Liabilities, Current
FOXO TECHNOLOGIES INC. (FOXO) had Accrued Liabilities, Current of $12.43 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $12.43M.
- 2026-03-31: Accrued Liabilities, Current $12.79M.
- 2025-12-31: Accrued Liabilities, Current $11.90M.
- 2025-09-30: Accrued Liabilities, Current $12.73M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $12.43M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $12.79M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $11.90M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $12.73M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $12.70M 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $13.10M 10-Q/A · filed 2025-08-19 | |
| 2024-12-31 | $11.99M 10-K · filed 2026-04-15 | $13.52M 10-K · filed 2025-04-15 |
| 2024-09-30 | $12.56M 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $1.95M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $1.81M 10-Q · filed 2024-06-28 | |
| 2023-12-31 | $3.98M 10-K · filed 2025-04-15 | $1.70M 10-K · filed 2024-06-06 |
| 2023-09-30 | $1.53M 10-Q/A · filed 2024-06-04 | |
| 2023-06-30 | $1.40M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.21M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.04M 10-K · filed 2024-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |